Drug Type Monoclonal antibody |
Synonyms |
Target |
Action inhibitors |
Mechanism RTN4 inhibitors(Reticulon-4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
acute spinal cord injury | Phase 1 | Germany | 18 Dec 2024 | |
acute spinal cord injury | Phase 1 | Switzerland | 18 Dec 2024 | |
Diabetic Retinopathy | Phase 1 | Switzerland | 30 Jun 2021 | |
Spinal Cord Injuries | Preclinical | Switzerland | 23 Oct 2023 |